New drug could extend the lives of breast cancer patients

LMU researchers have successfully tested a new drug which can significantly extend the lives of breast cancer patients.

Lilly partners with Haya for lncRNA obesity target deal worth $1bn – Pharmaceutical Technology

Eli Lilly and Haya Therapeutics aim to find multiple regulatory genome derived RNA-based drug targets for obesity. Credit: eamesBot via Shutterstock. Pharma giant Eli Lilly

September 5, 2024

eHealth app helps patients recover from major abdominal operations 30% faster

Through the use of eHealth application ikHerstel, patients recover from major abdominal operations 30% faster than patients who do not use the app.

July 6, 2023

Under-the-skin injection of Eisai’s Leqembi is as effective as IV infusion, new Alzheimer’s data show

A version of the Alzheimer’s disease drug Leqembi that can be given with a simpler, under-the-skin injection is equally effective as the currently approved intravenous

October 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.